Letter: improvement of clinical outcomes by metformin in metabolic liver disease-a microbiota-dependent mechanism?

Gianluca Ianiro; Francesca Romana Ponziani; Antonio Gasbarrini; Giovanni Cammarota

doi:10.1111/apt.15391

Letter: improvement of clinical outcomes by metformin in metabolic liver disease-a microbiota-dependent mechanism?

Research output: Contribution to journal › Article

Abstract

N/A

Original language	English
Pages (from-to)	474-N/A
Journal	Alimentary Pharmacology and Therapeutics
Volume	50
Issue number	4
DOIs	https://doi.org/10.1111/apt.15391
Publication status	Published - 2019

All Science Journal Classification (ASJC) codes

Hepatology
Gastroenterology
Pharmacology (medical)

Keywords

Letter: improvement of clinical outcomes by metformin in metabolic liver disease-a microbiota-dependent

Access to Document

10.1111/apt.15391

Cite this

@article{86500fb375994f2094b0246a58235c49,

title = "Letter: improvement of clinical outcomes by metformin in metabolic liver disease-a microbiota-dependent mechanism?",

abstract = "N/A",

keywords = "Letter: improvement of clinical outcomes by metformin in metabolic liver disease-a microbiota-dependent, Letter: improvement of clinical outcomes by metformin in metabolic liver disease-a microbiota-dependent",

author = "Gianluca Ianiro and Ponziani, \{Francesca Romana\} and Antonio Gasbarrini and Giovanni Cammarota",

year = "2019",

doi = "10.1111/apt.15391",

language = "English",

volume = "50",

pages = "474--N/A",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "1365-2036",